Literature DB >> 29883670

Dose-dependent effects of adenosine antagonists on tacrine-induced tremulous jaw movements.

Joel A Johnson1, Aaron P Montgomery2, Eric R Starr3, Justin Ludwig4, Jennifer Trevitt5.   

Abstract

The present study examines the effect of three adenosine receptor antagonists on tremulous jaw movements (TJMs), an animal model of tremor. Forty-five rats were pre-treated with one adenosine antagonist: caffeine (0.0, 5.0, or 10.0 mg/kg; non-selective adenosine receptor antagonist), 8-cyclopentyltheophylline (CPT; 0.0, 5.0, or 10.0 mg/kg; selective adenosine A1 receptor antagonist), or SCH 58261 (0.0 or 8.0 mg/kg; selective adenosine A2A receptor antagonist) followed by TJM induction with tacrine (0.0, 0.75, or 2.5 mg/kg; acetylcholinesterase inhibitor). CPT and SCH 58261 both significantly reduced TJMs while caffeine did not. Unexpectedly, both SCH 58261 and CPT reduced TJMs even in the absence of tacrine. Also, CPT showed a robust reduction of TJMs, achieved at both (5.0 mg/kg) and (10.0 mg/kg) doses and regardless of tacrine dose. In conclusion, this study shows adenosine receptor antagonism to generally suppress low-dose tacrine-induced TJMs. In concert with two prior studies, these results are suggestive of behavioral evidence for a biphasic effect of adenosine A2A receptor antagonists (caffeine and SCH 58261) that is modulated by tacrine, and a model of this effect is proposed. Published by Elsevier B.V.

Entities:  

Keywords:  Acetylcholine; Adenosine; Basal ganglia; Movement; Tacrine; Tremor

Mesh:

Substances:

Year:  2018        PMID: 29883670     DOI: 10.1016/j.ejphar.2018.06.004

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Discovery of a High Affinity Adenosine A1/A3 Receptor Antagonist with a Novel 7-Amino-pyrazolo[3,4-d]pyridazine Scaffold.

Authors:  Anna Suchankova; Margarita Stampelou; Klontiana Koutsouki; Athanasios Pousias; Lakshiv Dhingra; Kerry Barkan; Nicole Pouli; Panagiotis Marakos; Roxane Tenta; Antonios Kolocouris; Nikolaos Lougiakis; Graham Ladds
Journal:  ACS Med Chem Lett       Date:  2022-05-31       Impact factor: 4.632

2.  Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.

Authors:  Martina Ott; Karl-Heinz Tomaszowski; Anantha Marisetty; Ling-Yuan Kong; Jun Wei; Maya Duna; Katia Blumberg; Xiaorong Ji; Carmen Jacobs; Gregory N Fuller; Lauren A Langford; Jason T Huse; James P Long; Jian Hu; Shulin Li; Jeffrey S Weinberg; Sujit S Prabhu; Raymond Sawaya; Sherise Ferguson; Ganesh Rao; Frederick F Lang; Michael A Curran; Amy B Heimberger
Journal:  JCI Insight       Date:  2020-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.